Skip to main content
. 2023 Apr 14;12(4):759. doi: 10.3390/antibiotics12040759

Table 3.

Univariate and multivariate analyses of risk factors for CPE acquisition after hospitalization a (n = 77).

Characteristic Univariate Analysis Multivariate Analysis
OR (CI) p-Value aOR (CI) p-Value
Age
≥70 years (ref. <70 years) 0.32 (0.012–0.89) 0.029 0.51 (0.16–1.63) 0.257
Sex
Male (ref. Female) 2.13 (0.80–5.65) 0.131 1.63 (0.53–5.02) 0.396
Hospitalization history of other hospitals within 3 months
Yes (ref. No) 0.24 (0.09–0.69) 0.007 0.32 (0.10–0.98) 0.047
Admission route (ref. ER)
Ward 1.43 (0.49–4.17) 0.510 1.54 (0.49–4.87) 0.462
ICU 10.94 (1.88–63.68) 0.008 7.14 (1.09–46.80) 0.040
Comorbidity
Yes (ref. None) 0.65 (0.13–3.16) 0.596 0.77 (0.10–6.08) 0.800
Treatment in ICU
Yes (ref. None) 17.22 (5.21–56.91) <0.001 46.72 (5.08–430.09) <0.001
Open wound
Yes (ref. No) 2.49 (0.94–6.63) 0.068 5.99 (1.52–23.60) 0.011
Surgery b
Yes (ref. No) 1.98 (0.63–6.25) 0.244 2.84 (0.76–10.66) 0.121
Invasive device (ref. None)
Urinary catheter 3.85 (1.16–12.81) 0.028 4.56 (1.13–18.39) 0.033
Central catheter 9.74 (3.22–29.52) <0.001 11.94 (2.98–47.93) <0.001
Gastrointestinal tube 4.67 (1.63–13.38) 0.004 12.70 (2.61–61.84) 0.002
Drainage tube 0.98 (0.22–4.27) 0.977 1.03 (0.21–5.18) 0.968
Mechanical ventilation 5.90 (1.38–25.21) 0.017 4.86 (0.86–27.49) 0.074
Antibiotic exposure (ref. None)
Carbapenems 3.08 (1.15–8.27) 0.025 4.88 (1.40–16.95) 0.013
Glycopeptides 4.61 (1.57–13.55) 0.006 5.13 (1.46–18.00) 0.011
Penicillins 1.47 (0.56–3.88) 0.772 1.00 (0.32–3.14) 0.998
Cephalosporins 1.54 (0.59–4.03) 0.380 1.42 (0.47–4.26) 0.536
Fluoroquinolones 1.21 (0.47–3.14) 0.692 1.51 (0.49–4.71) 0.474
Vancomycin 2.19 (0.57–8.39) 0.252 3.89 (0.80–18.89) 0.092

CPE, carbapenemase-producing Enterobacteriaceae; ER, emergency room; ICU, intensive care unit; OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval. a Reference group = CPE colonization on admission, b Excluding simple surgery.